1 EXHIBIT 11.1 COULTER PHARMACEUTICAL, INC. STATEMENT OF COMPUTATION OF NET LOSS PER SHARE December 31, December 31, 1995 1996 ------------ ------------ Historical primary EPS Shares used in calculation of net loss per share: Weighted average common stock outstanding: 257 107,780 Shares related to Staff Accounting Bulletins Nos. 55, 64 and 83 Common stock: 401,788 301,341 Stock options: 559,600 419,700 Warrants: 173,067 129,800 Preferred stock; if converted 3,321,514 2,491,136 ----------- ------------ 4,456,226 3,449,757 ----------- ------------ Net (loss) $(2,992,557) $(15,338,279) ----------- ------------ Net (loss) per share $(0.67) $(4.45) =========== ============ Proforma: Shares used in calculation of net loss per share: Weighted average common stock outstanding: 257 107,780 Preferred Stock, if converted 2,341,665 4,108,154 Shares related to Staff Accounting Bulletins Nos. 55, 64 and 83 Common stock: 401,788 301,341 Stock options: 559,600 419,700 Warrants: 173,067 129,800 Preferred stock; if converted 3,321,514 2,491,136 ----------- ------------ 6,797,891 7,557,911 ----------- ------------ Net (loss) $(2,992,557) $(15,338,279) ----------- ------------ Net (loss) per share $(0.44) $(2.03) =========== ============